>>> http://www.freepatentsonline.com/EP2631248A3.html
Title: Treatment of tumors using specific anti-L1 antibody
Document Type and Number: European Patent Application EP2631248
Kind Code: A3
Abstract: The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.
Inventors: Kelm, Daniela (Hegelstr. 24, 71711 Steinheim an der Murr, DE); Altevogt, Peter (Adolf-Kolping-Str. 3, 69151 Neckargemünd, DE); Lüttgau, Sandra (Blumenstr. 38, 86596 Schongau, DE); Krüger, Achim (Stefan-Georg-Ring 57, 81929 München, DE); Moldenhauer, Gerhard (Keplerstr. 22, 69120 Heidelberg, DE); Breitling, Frank (Bergheimer Str. 123, 69115 Heidelberg, DE); Bärreiter, Silke (Im Bärle 33, 69469 Weinheim, DE); Li, Yi (16 The CroftWest Hanney, Wantage Oxfordshire, OX12 L0D, GB);
Möbius, Ulrich (Am Rain 7, 82131 Gauting, DE); Sebens, Prof. Dr. Susanne (Gneisenaustr. 25, 24105 Kiel, DE); Schäfer, Prof. Dr. Heiner (Gerhardstr. 10, 24105 Kiel, DE)
Application Number: EP20130000027
Publication Date: 10/23/2013
Filing Date: 06/13/2008
Assignee: Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts (Im Neuenheimer Feld 280, 69120 Heidelberg, DE)
MediGene AG (Lochhamer Strasse 11, 82152 Martinsried, DE)
International Classes: C07K16/28
Attorney, Agent or Firm: Lahrtz, Fritz (Isenbruck Bösl Hörschler LLP Patentanwälte Prinzregentenstrasse 68, 81675 München, DE) |
Thread abonnieren
